Mipomersen, an Apolipoprotein B Synthesis Inhibitor, Reduces Atherogenic Lipoproteins in Patients With Severe Hypercholesterolemia at High Cardiovascular Risk-Reference-Cited by-同舟云学术

Mipomersen, an Apolipoprotein B Synthesis Inhibitor, Reduces Atherogenic Lipoproteins in Patients With Severe Hypercholesterolemia at High Cardiovascular Risk

Published:2013-12 Issue:23 Volume:62 Page:2178-2184
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Thomas Gregory S.,Cromwell William C.,Ali Shariq,Chin Wai,Flaim JoAnn D.,Davidson Michael

Funder

Isis Pharmaceuticals and Genzyme Corporation

Genzyme, Regeneron, and sanofi-aventis

Isis Pharmaceuticals

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference19 articles.

1. Transfer of low density lipoprotein into the arterial wall and risk of atherosclerosis;Nielsen;Atherosclerosis,1996

2. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications;Tabas;Circulation,2007

3. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines;Grundy;Circulation,2004

4. Combination therapy in cholesterol reduction: focus on ezetimibe and statins;Grigore;Vasc Health Risk Manag,2008

5. Emerging targets for the treatment of dyslipidemia;Tavridou;Curr Med Chem,2011

Cited by 217 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nucleic Acid Therapy for the Skin;Journal of Investigative Dermatology;2024-09

2. Down syndrome and DYRK1A overexpression: relationships and future therapeutic directions;Frontiers in Molecular Neuroscience;2024-07-24

3. The relationship between triglyceride/high-density lipoprotein cholesterol ratio and the severity of coronary artery disease in patients presenting with acute coronary syndrome;Coronary Artery Disease;2024-05-03

4. Residual Cardiovascular Risk: Role of Remnants Cholesterol, Monocyte/HDL Ratio and Lipoprotein Ratios on Personalized Cardiovascular Prevention;Journal of Personalized Medicine;2024-04-26

5. Cholesterol-Lowering Strategies for Cardiovascular Disease Prevention: The Importance of Intensive Treatment and the Simplification of Medical Therapy;Journal of Clinical Medicine;2024-03-25